Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development
- PMID: 27528060
- DOI: 10.2174/0929867323666160813222436
Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development
Abstract
Over the years, natural products have shown success as antidiabetics in in vitro, in vivo studies and clinical trials. Because natural product-derived drugs are more affordable and effective with fewer side-effects compared to conventional therapies, pharmaceutical research is increasingly leaning towards the discovery of new antidiabetic drugs from natural products targeting pathways or components associated with type 2 diabetes mellitus (T2DM) pathophysiology. However, the drug discovery process is very lengthy and costly with significant challenges. Therefore, various techniques are currently being developed for the preclinical research phase of drug discovery with the aim of drug development with less time and efforts from natural products. In this review, we have provided an update on natural products including fruits, vegetables, spices, nuts, beverages and mushrooms with potential antidiabetic activities from in vivo, in vitro and clinical studies. Synergistic interactions between natural products and antidiabetic drugs, and potential antidiabetic active compounds from natural products are also documented to pave the way for combination treatment and new drug discovery, respectively. Additionally, a brief idea of the drug discovery process along with the challenges that arise during drug development from natural products and the methods to conquer those challenges are discussed to create a more convenient future drug discovery process.
Keywords: Type 2 diabetes mellitus; antidiabetic drugs; drug development; in vitro; in vivo; natural products; synergistic interaction..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Oral antidiabetic agents: current role in type 2 diabetes mellitus.Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005. Drugs. 2005. PMID: 15669880 Review.
-
Editorial: Natural Compounds and Their Derivatives as a Source of Promising Drugs for Diabetes and Insulin Resistance.Curr Drug Targets. 2017;18(6):618. doi: 10.2174/138945011806170330194537. Curr Drug Targets. 2017. PMID: 28831919 No abstract available.
-
Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.Molecules. 2020 Dec 3;25(23):5713. doi: 10.3390/molecules25235713. Molecules. 2020. PMID: 33287318 Free PMC article. Review.
-
Exploring Natural Products as a Source for Antidiabetic Lead Compounds and Possible Lead Optimization.Curr Top Med Chem. 2016;16(23):2549-61. doi: 10.2174/1568026616666160414123602. Curr Top Med Chem. 2016. PMID: 27086794 Review.
-
Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus.Mini Rev Med Chem. 2019;19(11):880-901. doi: 10.2174/1389557519666181128120726. Mini Rev Med Chem. 2019. PMID: 30484403 Review.
Cited by
-
Identification of Bioactive Components from Ruellia tuberosa L. on Improving Glucose Uptake in TNF-α-Induced Insulin-Resistant Mouse FL83B Hepatocytes.Evid Based Complement Alternat Med. 2020 Dec 1;2020:6644253. doi: 10.1155/2020/6644253. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33335557 Free PMC article.
-
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity.Diabetes Metab Syndr Obes. 2020 Oct 12;13:3627-3635. doi: 10.2147/DMSO.S265399. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 33116714 Free PMC article. Review.
-
Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment.Aging (Albany NY). 2022 Mar 24;14(6):2902-2919. doi: 10.18632/aging.203969. Epub 2022 Mar 24. Aging (Albany NY). 2022. PMID: 35332108 Free PMC article. Review.
-
A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology.BMC Complement Med Ther. 2020 Mar 6;20(1):72. doi: 10.1186/s12906-020-2871-3. BMC Complement Med Ther. 2020. PMID: 32143602 Free PMC article.
-
Evaluation of the Hypoglycemic and Hypolipidemic Potential of Extract Fraction of Quercus baloot Griff Seeds in Alloxan-induced Diabetic Mice.Curr Pharm Des. 2024;30(37):2978-2991. doi: 10.2174/0113816128319184240827070016. Curr Pharm Des. 2024. PMID: 39219120
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical